Submissions/Responses
A significant component of HCASA’s systemic advocacy and policy role has been to ensure and promote the consumer voice to influence and shape government and health policy. In its final two years HCASA made formal submissions to more than twenty state and national policy drafts. To ensure that consumer voices are heard, HCASA conducted consumer surveys, focus groups, workshops and informal meetings and interviews to gather consumer perspectives and responses to these submissions.
HCASA consulted the Consumer Advocates Network, broader consumer stakeholders and mailing lists, consumer and community organisations and groups and the members of Consumer Advisory Committees across South Australia to inform these submissions.
A cross section of HCASA Submissions in the past few years include (but are not limited to):
- Joint Submission to the Senate Inquiry into the number of women in Australian who have had transvaginal mesh implants and related matters (May 2017)
- HCASA Consumer Response to the Draft Australian Charter of Health Care Rights (November 2018)
- HCASA Submission to SA Health on the feasibility of trialling a model of mandatory assessment and/or treatment for those at extreme risk associated with severe substance dependence (February 2018)
- HCASA Response to the Review of the Restraint and Seclusion in Mental Health Services Policy Guideline and Associated Documents (April 2018)
- Response to Therapeutic Goods Administration Consultation Paper: Prescription strong (Schedule 8) opioid use and misuse in Australia – options for a regulatory response (February 2018)
- HCASA Submission on the My Health Record Senate Inquiry Consultation Paper (August 2018)
- HCASA Submission to the Parliamentary Committee on Occupational Safety, Rehabilitation and Compensation- Inquiry into Workplace Fatigue and Bullying in South Australian Hospitals and health Services (January 2019)
- Response to the SA Health Consultation – Draft Clinical Communication and Patient Identification Clinical Directive (January 2019)
- Response to Therapeutic Goods Administration Consultation – Proposal to introduce a Unique Device Identification (UDI) system for medical devices in Australia (January 2019)
- Response and Recommendations to the Select Committee on Matters Relating to SA Pathology and SA Medical Imaging (February 2019)
- Response to Therapeutic Goods Administration Consultation – Changes to a number of definitions and scope of medical device regulatory framework in Australia (February 2019)
- Response to Therapeutic Goods Administration Consultation – Scope of regulated (health) software-based products (February 2019)
- Response to Therapeutic Goods Administration Consultation – Medical Device Cyber Security (February 2019)
- Response to the Draft South Australian Clinical Genomics Plan 2022 (April 2019)
- Response to the South Australian SA Health: Health and Wellbeing Strategy 2019-2024 Summary Framework for Consultation (April 2019)
- Response to the Advance Care Directive 5 Year Review (May 2019)
- Consultation Report on the Draft NSQHSS Standards aged Care Module (July 2019)
- Consumer Response to the Commission on Excellence and Innovation in Health Discussion paper – role and purpose of the commission (August 2019)
- Response and Recommendations to the Select Committee on Health Services in South Australia (August 2019)
- HCASA Consumer Submission to the Parliamentary Standing Committee: Social Development Committee Surgical Implantation of Medical Mesh in South Australia (September 2019)
- HCASA Consumer Response to the Draft Wellbeing SA 2020-2025 Framework (December 2019)
- Joint Statement on the Amendments to the Health Care (Governance) Amendment Bill (2019)